One River Asset Management’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

One River Asset Management’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-60,000	Closed	-$5.36M	–	353
2023 Q4	$5.36M	Hold	60,000	–	–	0.12%	127
2023 Q3	$4.38M	Buy	+60,000	New	+$4.79M	0.14%	124

Other funds holding XBI

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $155B AUM 29.93% 1-Year Est. Return

One River Asset Management's XBI Position: Q1 2024 in Review

One River Asset Management sold out of State Street SPDR S&P Biotech ETF (XBI) in Q1 2024, closing a stake of 26,400 shares — an estimated $2.36M sold.

One River Asset Management first reported a position in XBI in Q3 2023 and held it in 2 quarters. The position peaked at $2.36M in Q4 2023. 780 funds tracked by Wall St. Rank hold XBI as of Q1 2024.

One River Asset Management reported no remaining State Street SPDR S&P Biotech ETF position as of Q1 2024 after selling out during the quarter.
One River Asset Management sold 26,400 State Street SPDR S&P Biotech ETF shares in Q1 2024, an estimated $2.36M.
One River Asset Management first reported a position in State Street SPDR S&P Biotech ETF in Q3 2023 and held it in 2 quarters.
One River Asset Management's State Street SPDR S&P Biotech ETF position peaked at $2.36M in Q4 2023.
780 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q1 2024.

Based on One River Asset Management's 13F filing for Q1 2024, filed 14 May 2024.